On August 10, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, announced, "We are raising the target price of SK Chemicals to 450,000 KRW, reflecting the expected performance of SK Bioscience, a subsidiary of SK Chemicals, in the COVID-19 vaccine CMO business."
Over the past five days, individual investors have net sold 143,217 shares of SK Chemicals, while foreign investors and institutions have net sold 11,097 shares and net bought 119,685 shares, respectively.

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
